Clinical Trial Update: Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study [Phase 2]

View source ↗

Summary

A Phase 2 trial (MYSTAR) from the Medical University of Vienna evaluated administration of myocardial stem cells after acute myocardial infarction; the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Medical University of Vienna | Conditions: Myocardial Infarction | Phase 2 | Status: COMPLETED